Source: Medical Device News Magazine

Micro Interventional Devices, Inc.: Micro Interventional Devices Submits CE Mark Technical Documentation for the MIA-T Percutaneous Tricuspid Annuloplasty System

The receipt of a CE Mark would allow MID to commercialize MIA-T in the European Union in countries governed by the European Medical Device Regulations (MDR). MID is anticipating an approval in 2021.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Michael P. Whitman's photo - President & CEO of MID

President & CEO

Michael P. Whitman

CEO Approval Rating

91/100

Read more